PLUS vs UTHR · P/E 17, rev $2.07B vs P/E 20, rev $2.88B
ePlus inc (PLUS) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
PLUS currently screens at market cap $2.10B and trailing P/E 17.1. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the PLUS and UTHR stock pages for the full models.
Not investment advice.